Skip to main content
. 2023 Jun 30;49(3):135–141. doi: 10.5125/jkaoms.2023.49.3.135

Table 2.

Parameter comparison

MRONJ P-value

No (control group, n=210) Yes (MRONJ group, n=130)
Age (yr) 73.1±9.0 77.2±7.1 <0.0011
Medication administration
Oral 82 (39.0) 70 (53.8) <0.0012
Intravenous 98 (46.7) 29 (22.3)
Both 30 (14.3) 31 (23.8)
Duration of medication (yr) 3.4±4.6 5.8±5.1 <0.0011
Medical history
Hypertension 104 (49.5) 85 (65.4) 0.0042
Hyperlipidemia 47 (22.4) 27 (20.8) 0.726
Anticoagulant 29 (13.8) 14 (10.8) 0.412
Diabetes mellitus 41 (19.5) 29 (22.3) 0.552
Heart disease 23 (11.0) 24 (18.5) 0.051
Thyroid disease 10 (4.8) 7 (5.4) 0.798
Liver disease 4 (1.9) 0 (0) 0.113
Kidney disease 10 (4.8) 4 (3.1) 0.447
Rheumatoid arthritis 4 (1.9) 7 (5.4) 0.078
Cancer 10 (4.8) 12 (9.2) 0.104
Dementia 11 (5.2) 2 (1.5) 0.084
Method of operation
Extraction 180 (85.7) 99 (76.2) 0.0262
Implantation 30 (14.3) 31 (23.8)
No. of operated teeth 2.3±1.6 1.7±1.0 <0.0011
Operation area
Maxilla 93 (44.3) 35 (26.9) <0.0012
Mandible 87 (41.4) 90 (69.2)
Both 30 (14.3) 5 (3.8)

(MRONJ: medication-related osteonecrosis of the jaw)

Statistical analyses by 1Student’s t-test and 2chi-square test.

Values are presented as mean±standard deviations or number (%).